CIAM
OCUL icon

Caitong International Asset Management’s Ocular Therapeutix OCUL Stock Holding History

Caitong International Asset Management’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12K Sell
1,227
-39,759
-97% -$360K ﹤0.01% 1117
2026
Q1 		$347K Buy
40,986
+30,968
+309% +$295K 0.06% 251
2025
Q4 		$122K Buy
10,018
+8,785
+712% +$107K 0.03% 354
2025
Q3 		$14.4K Buy
1,233
+36
+3% +$430 0.01% 882
2025
Q2 		$11.1K Buy
1,197
+1,128
+1,635% +$8.83K 0.01% 685
2025
Q1 		$506 Buy
+69
New +$530 ﹤0.01% 1769

Other funds holding OCUL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $161M AUM 27.24% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Caitong International Asset Management's OCUL Position: Q2 2026 in Review

Caitong International Asset Management reduced its Ocular Therapeutix (OCUL) stake by 97% in Q2 2026, selling an estimated $360K and leaving 1,227 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #1117.

Caitong International Asset Management first reported a position in OCUL in Q1 2025 and has held it in 6 quarters since. The position peaked at $347K in Q1 2026. 261 funds tracked by Wall St. Rank hold OCUL as of Q2 2026.

  • Caitong International Asset Management held 1,227 shares of Ocular Therapeutix worth $12K as of Q2 2026.
  • Caitong International Asset Management sold 39,759 Ocular Therapeutix shares in Q2 2026, an estimated $360K.
  • Ocular Therapeutix made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #1117 holding.
  • Caitong International Asset Management first reported a position in Ocular Therapeutix in Q1 2025 and has held it in 6 quarters since.
  • Caitong International Asset Management's Ocular Therapeutix position peaked at $347K in Q1 2026.
  • 261 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.